BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 12244078)

  • 1. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.
    Kuhlmann T; Lingfeld G; Bitsch A; Schuchardt J; Brück W
    Brain; 2002 Oct; 125(Pt 10):2202-12. PubMed ID: 12244078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
    Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A
    Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The evidence for primary axonal loss in multiple sclerosis].
    Anthony DC; Hughes P; Perry VH
    Rev Neurol; 2000 Jun 16-30; 30(12):1203-8. PubMed ID: 10935251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive acute axonal damage in pediatric multiple sclerosis lesions.
    Pfeifenbring S; Bunyan RF; Metz I; Röver C; Huppke P; Gärtner J; Lucchinetti CF; Brück W
    Ann Neurol; 2015 Apr; 77(4):655-67. PubMed ID: 25612167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E; Pardo LA; Gold R; Linker RA
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination and axonal damage in a non-human primate model of multiple sclerosis.
    Mancardi G; Hart B; Roccatagliata L; Brok H; Giunti D; Bontrop R; Massacesi L; Capello E; Uccelli A
    J Neurol Sci; 2001 Feb; 184(1):41-9. PubMed ID: 11231031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis - remyelination failure as a cause of disease progression.
    Hagemeier K; Brück W; Kuhlmann T
    Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.
    Höflich KM; Beyer C; Clarner T; Schmitz C; Nyamoya S; Kipp M; Hochstrasser T
    Brain Res; 2016 Nov; 1650():125-133. PubMed ID: 27592741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal damage in acute multiple sclerosis lesions.
    Ferguson B; Matyszak MK; Esiri MM; Perry VH
    Brain; 1997 Mar; 120 ( Pt 3)():393-9. PubMed ID: 9126051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
    Bouafia A; Golmard JL; Thuries V; Sazdovitch V; Hauw JJ; Fontaine B; Seilhean D
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):579-90. PubMed ID: 23659577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases.
    Neumann H
    Curr Opin Neurol; 2003 Jun; 16(3):267-73. PubMed ID: 12858061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis.
    Schirmer L; Antel JP; Brück W; Stadelmann C
    Brain Pathol; 2011 Jul; 21(4):428-40. PubMed ID: 21114565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
    Garay L; Gonzalez Deniselle MC; Meyer M; Costa JJ; Lima A; Roig P; De nicola AF
    Brain Res; 2009 Aug; 1283():177-85. PubMed ID: 19497309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.